Surveillance report examines nonprescription hormone use among transgender women in U.S. urban areas.

This publication is an observational surveillance report, not a formal study. It examined demographic, healthcare, and economic correlates of nonprescription hormone use among a population of transgender women across seven urban areas in the United States. The sample size, specific outcomes, and any comparator group were not reported.

No main results, such as prevalence rates or specific associations, were provided in the available data. Similarly, no information on safety, adverse events, tolerability, or follow-up duration was reported.

Key limitations include the lack of reported findings, outcomes, and methodological details, which severely restricts interpretation. The practice relevance is not reported, and the report's primary utility is as a descriptive snapshot of a public health surveillance effort rather than a source of clinical evidence.